After graduating, I started a rotating internship at the Massilia Veterinary Hospital in Marseille. I began a surgery internship the following year. My interest in osteochondrodysplasia in Scottish fold cats was sparked when a cat with this condition was admitted to the hospital. My mentor, Luis, and I started researching the condition from that point forward.
My motivation came from the lack of consensus in veterinary literature regarding the management of osteochondrodysplasia in Scottish fold cats. We had achieved great results by treating a case with brachytherapy at Massilia Veterinary Hospital. We believed that sharing our experience could be beneficial to surgeons and referring veterinarians, offering an effective palliative solution for Scottish fold cats suffering from this condition.
Our poster presented a case report on a Scottish fold cat that we treated with brachytherapy. Osteochondrodysplasia is an inherited disease, causing skeletal deformities in distal limbs and the tail. Affected cats exhibit lameness, reluctance to jump and run, decreased range of motion, or ankylosis due to bone formation around distal joints. There is limited clinical data on osteochondrodysplasia in Scottish fold cats.
Treatments are primarily palliative, aiming to manage pain and improve clinical signs. We found that brachytherapy was an efficient treatment for osteochondrodysplasia, delivered promising long-term results, with improved gait and pain relief within two weeks, allowing the cat to return to normal activity without recurrence for 16 months.
It was my first time attending an ECVS congress and my first international presentation, so I'm very grateful for the visibility provided by the ECVS committee and the opportunity Luis gave me to present our work.
The results we obtained with brachytherapy for our cat closely resemble those reported with radiotherapy. Significant improvement is noted within the first two weeks following treatment, with a return to normal activity in a few weeks.
Transitioning from radiotherapy to brachytherapy resulted in fewer sessions and a lower total dose for brachytherapy, reducing the need for general anaesthesia. However, both radiotherapy and brachytherapy remain palliative treatments that do not halt the progression of the disease.
Luis has been a constant source of support throughout the process, not just for this project but throughout my career. I am deeply grateful for his guidance.
Additionally, Benoit Simian-Salvay, the clinical director responsible for brachytherapy at our hospital, played a vital role in converting radiotherapy treatment into brachytherapy. Marlène Finck and Antonin Martenne-Duplan, the head of the medical imaging department and ECVDI resident, were instrumental in overseeing radiographic and CT-scan exams. Many of my coworkers from St Martin Hospital in Annecy, where I was working at the time, helped me with the poster and the presentation.
We aim to recruit more cases of osteochondrodysplasic Scottish fold cats, with a longer follow-up period to gain a deeper understanding of the long-term effects of this treatment, and to identify the population that could benefit from brachytherapy.
For this poster presentation, IVC Evidensia provided assistance with travel and conference expenses, which was invaluable. Furthermore, IVC Evidensia offers opportunities to contribute to research by providing financial support and necessary equipment.
I am currently applying for a grant for a research project on elbow dysplasia in dogs in collaboration with the surgical team at Fregis Veterinary Hospital in Paris, where I currently work.
I would recommend applying for research grants when financial support is required; it can be highly beneficial. And do not hesitate to connect with other clinic members and collaborate on research projects!
I am finalising a research project on tendinous repair and intend to initiate a study on elbow dysplasia in Paris as soon as possible. A case report with Luis is also in the pipeline.
My goal is to commence a surgery residency next summer, with the aim of becoming an ECVS specialist and continuing to contribute to research to enhance the quality of care in surgery for our patients.